Cargando…
Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. In cases where no overt option for immune reconstitution is available [e.g., in patients with primary immunodeficiency (PID)], the disease is leth...
Autores principales: | Volk, Timo, Warnatz, Klaus, Marks, Reinhard, Urbach, Horst, Schluh, Gisela, Strohmeier, Valentina, Rojas-Restrepo, Jessica, Grimbacher, Bodo, Rauer, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782776/ https://www.ncbi.nlm.nih.gov/pubmed/34196768 http://dx.doi.org/10.1007/s00415-021-10682-8 |
Ejemplares similares
-
Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency
por: Küpper, Clemens, et al.
Publicado: (2019) -
Single-Dose Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
por: Beudel, Martijn, et al.
Publicado: (2021) -
Sequential interleukin 2 and pembrolizumab use in progressive multifocal leukoencephalopathy
por: Mahler, Christoph, et al.
Publicado: (2020) -
PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy
por: Möhn, Nora, et al.
Publicado: (2021) -
Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab
por: Boesl, Fabian, et al.
Publicado: (2022)